Physician profile
Michael Carl
NPI 1700858057
$2,116.11
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $88.70 · 2022: $203 · 2023: $1,653 · 2024: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,016 · Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,016.48 |
| Food and Beverage | $807.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,003.63 | 2023 | Intracept |
| Curonix LLC | $361.09 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $327.61 | 2021-2024 | Intracept, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $162.62 | 2023 | Intellis Adaptivestim, Ascenda |
| Vertos Medical, INC. | $143.37 | 2022-2023 | Mild Device Kit |
| Painteq LLC | $74.46 | 2023 | Painteq |
| Pacira Therapeutics, INC. | $22.39 | 2021 | |
| Abbott Laboratories | $20.94 | 2024 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Carl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.